Impact of pain on the outcomes of depression treatment: Results from the RESPECT trial

Kurt Kroenke, Jianzhao Shen, Thomas E. Oxman, John W. Williams, Allen J. Dietrich

Research output: Contribution to journalArticle

111 Citations (Scopus)

Abstract

Objective: Pain is prevalent in patients with depression. The purpose of this study was to determine the impact of pain on depression treatment outcomes. Methods: Data was analyzed from a randomized controlled trial comparing a collaborative care intervention to usual care for the treatment of depression in 60 primary care practices. A total of 405 patients with either current major depressive disorder or dysthymia were enrolled, and assessed at baseline, 3, and 6 months. Main measures included the 20-item Hopkins Symptom Check List (HSCL-20) depression score, and the SF-36 pain interference score. Results: Pain severe enough to produce at least moderate interference with daily activities was present in 42% of depressed patients at baseline. Pain outcomes did not differ between intervention and control groups but improved similarly in both over time. However, pain was still at least moderately severe in 32% of patients at 6 months. Both baseline pain and the amount of pain improvement over time were associated with depression remission and response rates. In a multivariate model controlling for age, gender, and medical co-morbidity, depression severity increased with higher pain interference and decreased with the passage of time (p < .0001 for both). There was also a significant pain by time by treatment group interaction (p = .027). The beneficial effects of collaborative care on depression outcome persisted (p = .049) even after controlling for pain interference, time, covariates, and interaction effects. Conclusions: Pain has a strong negative impact on the response of depression to treatment. Recognizing and optimizing the management of comorbid pain that commonly coexists with depression may be important in enhancing depression response and remission rates.

Original languageEnglish
Pages (from-to)209-215
Number of pages7
JournalPain
Volume134
Issue number1-2
DOIs
StatePublished - Jan 2008

Fingerprint

Depression
Pain
Major Depressive Disorder
Pain Management
Primary Health Care
Therapeutics
Randomized Controlled Trials
Morbidity
Control Groups

Keywords

  • Depression
  • Pain
  • Primary care
  • Randomized clinical trial
  • Treatment

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Neurology
  • Neuroscience(all)
  • Pharmacology
  • Clinical Psychology

Cite this

Impact of pain on the outcomes of depression treatment : Results from the RESPECT trial. / Kroenke, Kurt; Shen, Jianzhao; Oxman, Thomas E.; Williams, John W.; Dietrich, Allen J.

In: Pain, Vol. 134, No. 1-2, 01.2008, p. 209-215.

Research output: Contribution to journalArticle

Kroenke, Kurt ; Shen, Jianzhao ; Oxman, Thomas E. ; Williams, John W. ; Dietrich, Allen J. / Impact of pain on the outcomes of depression treatment : Results from the RESPECT trial. In: Pain. 2008 ; Vol. 134, No. 1-2. pp. 209-215.
@article{88c5d7c71a264b93bfba1afd847b7dd4,
title = "Impact of pain on the outcomes of depression treatment: Results from the RESPECT trial",
abstract = "Objective: Pain is prevalent in patients with depression. The purpose of this study was to determine the impact of pain on depression treatment outcomes. Methods: Data was analyzed from a randomized controlled trial comparing a collaborative care intervention to usual care for the treatment of depression in 60 primary care practices. A total of 405 patients with either current major depressive disorder or dysthymia were enrolled, and assessed at baseline, 3, and 6 months. Main measures included the 20-item Hopkins Symptom Check List (HSCL-20) depression score, and the SF-36 pain interference score. Results: Pain severe enough to produce at least moderate interference with daily activities was present in 42{\%} of depressed patients at baseline. Pain outcomes did not differ between intervention and control groups but improved similarly in both over time. However, pain was still at least moderately severe in 32{\%} of patients at 6 months. Both baseline pain and the amount of pain improvement over time were associated with depression remission and response rates. In a multivariate model controlling for age, gender, and medical co-morbidity, depression severity increased with higher pain interference and decreased with the passage of time (p < .0001 for both). There was also a significant pain by time by treatment group interaction (p = .027). The beneficial effects of collaborative care on depression outcome persisted (p = .049) even after controlling for pain interference, time, covariates, and interaction effects. Conclusions: Pain has a strong negative impact on the response of depression to treatment. Recognizing and optimizing the management of comorbid pain that commonly coexists with depression may be important in enhancing depression response and remission rates.",
keywords = "Depression, Pain, Primary care, Randomized clinical trial, Treatment",
author = "Kurt Kroenke and Jianzhao Shen and Oxman, {Thomas E.} and Williams, {John W.} and Dietrich, {Allen J.}",
year = "2008",
month = "1",
doi = "10.1016/j.pain.2007.09.021",
language = "English",
volume = "134",
pages = "209--215",
journal = "Pain",
issn = "0304-3959",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Impact of pain on the outcomes of depression treatment

T2 - Results from the RESPECT trial

AU - Kroenke, Kurt

AU - Shen, Jianzhao

AU - Oxman, Thomas E.

AU - Williams, John W.

AU - Dietrich, Allen J.

PY - 2008/1

Y1 - 2008/1

N2 - Objective: Pain is prevalent in patients with depression. The purpose of this study was to determine the impact of pain on depression treatment outcomes. Methods: Data was analyzed from a randomized controlled trial comparing a collaborative care intervention to usual care for the treatment of depression in 60 primary care practices. A total of 405 patients with either current major depressive disorder or dysthymia were enrolled, and assessed at baseline, 3, and 6 months. Main measures included the 20-item Hopkins Symptom Check List (HSCL-20) depression score, and the SF-36 pain interference score. Results: Pain severe enough to produce at least moderate interference with daily activities was present in 42% of depressed patients at baseline. Pain outcomes did not differ between intervention and control groups but improved similarly in both over time. However, pain was still at least moderately severe in 32% of patients at 6 months. Both baseline pain and the amount of pain improvement over time were associated with depression remission and response rates. In a multivariate model controlling for age, gender, and medical co-morbidity, depression severity increased with higher pain interference and decreased with the passage of time (p < .0001 for both). There was also a significant pain by time by treatment group interaction (p = .027). The beneficial effects of collaborative care on depression outcome persisted (p = .049) even after controlling for pain interference, time, covariates, and interaction effects. Conclusions: Pain has a strong negative impact on the response of depression to treatment. Recognizing and optimizing the management of comorbid pain that commonly coexists with depression may be important in enhancing depression response and remission rates.

AB - Objective: Pain is prevalent in patients with depression. The purpose of this study was to determine the impact of pain on depression treatment outcomes. Methods: Data was analyzed from a randomized controlled trial comparing a collaborative care intervention to usual care for the treatment of depression in 60 primary care practices. A total of 405 patients with either current major depressive disorder or dysthymia were enrolled, and assessed at baseline, 3, and 6 months. Main measures included the 20-item Hopkins Symptom Check List (HSCL-20) depression score, and the SF-36 pain interference score. Results: Pain severe enough to produce at least moderate interference with daily activities was present in 42% of depressed patients at baseline. Pain outcomes did not differ between intervention and control groups but improved similarly in both over time. However, pain was still at least moderately severe in 32% of patients at 6 months. Both baseline pain and the amount of pain improvement over time were associated with depression remission and response rates. In a multivariate model controlling for age, gender, and medical co-morbidity, depression severity increased with higher pain interference and decreased with the passage of time (p < .0001 for both). There was also a significant pain by time by treatment group interaction (p = .027). The beneficial effects of collaborative care on depression outcome persisted (p = .049) even after controlling for pain interference, time, covariates, and interaction effects. Conclusions: Pain has a strong negative impact on the response of depression to treatment. Recognizing and optimizing the management of comorbid pain that commonly coexists with depression may be important in enhancing depression response and remission rates.

KW - Depression

KW - Pain

KW - Primary care

KW - Randomized clinical trial

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=37049001839&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37049001839&partnerID=8YFLogxK

U2 - 10.1016/j.pain.2007.09.021

DO - 10.1016/j.pain.2007.09.021

M3 - Article

C2 - 18022319

AN - SCOPUS:37049001839

VL - 134

SP - 209

EP - 215

JO - Pain

JF - Pain

SN - 0304-3959

IS - 1-2

ER -